Skip to main content
Signal8

GELSTAT CORP (GSAC)

GelStat Corporation operates as a consumer healthcare enterprise, specializing in the innovation, formulation, and commercialization of over-the-counter (OTC) and other non-prescription health solutions. Its diverse product portfolio addresses various common health concerns, featuring: GelStat Migraine, a patented remedy targeting migraine headache pain; Chews 2 Lose, an appetite-controlling gum designed to assist with weight management; All Natural Speed, formulated as an energy booster; and GelStat Sleep, intended to alleviate sleep disturbances and their related symptoms. GelStat distributes its solutions through a comprehensive network, reaching retailers, wholesalers, specialized distributors, and catalog merchandisers. This is achieved both through direct sales and via independent sales brokerage agreements. The corporation maintains its principal office in Palm City, Florida.

Sector: Pharmaceutical Preparations

Industry: Medical - Pharmaceuticals

GelStat Corporation logo

GelStat Corporation

OTC:GSACHealthcare
$0.0003
Mkt Cap$185K
Float530.21M
O/S617.98M
Inst Own-
SI<0.1%
Dilution
Delisting Issues Timeline
Financials Summary
Debt & Equity
Total Debt
Total Equity
Shares Outstanding
Short Interest
Split History1 split
  1. 2:1Forward split
    Oct 21, 20031 share → 2
Balance Sheet Details
Accounts Receivable
Accounts Payable
Inventory
PP&E (Net)
Goodwill
Intangible Assets
Income Statement
Balance Sheet
Cash Flow Statement